![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM266 |
Gene summary for TMEM266 |
![]() |
Gene information | Species | Human | Gene symbol | TMEM266 | Gene ID | 123591 |
Gene name | transmembrane protein 266 | |
Gene Alias | C15orf27 | |
Cytomap | 15q24.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q2M3C6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
123591 | TMEM266 | HTA11_3410_2000001011 | Human | Colorectum | AD | 6.39e-03 | 1.69e-01 | 0.0155 |
123591 | TMEM266 | HTA11_2487_2000001011 | Human | Colorectum | SER | 7.21e-08 | 3.19e-01 | -0.1808 |
123591 | TMEM266 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.30e-07 | 3.63e-01 | -0.0811 |
123591 | TMEM266 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.62e-18 | 4.05e-01 | -0.1954 |
123591 | TMEM266 | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.75e-08 | 3.51e-01 | -0.1207 |
123591 | TMEM266 | HTA11_696_2000001011 | Human | Colorectum | AD | 2.41e-10 | 3.32e-01 | -0.1464 |
123591 | TMEM266 | HTA11_866_2000001011 | Human | Colorectum | AD | 3.61e-05 | 2.00e-01 | -0.1001 |
123591 | TMEM266 | HTA11_1391_2000001011 | Human | Colorectum | AD | 4.50e-08 | 2.92e-01 | -0.059 |
123591 | TMEM266 | HTA11_2992_2000001011 | Human | Colorectum | SER | 1.29e-04 | 3.27e-01 | -0.1706 |
123591 | TMEM266 | HTA11_5216_2000001011 | Human | Colorectum | SER | 9.79e-08 | 4.12e-01 | -0.1462 |
123591 | TMEM266 | HTA11_866_3004761011 | Human | Colorectum | AD | 3.66e-02 | 1.13e-01 | 0.096 |
123591 | TMEM266 | HTA11_10711_2000001011 | Human | Colorectum | AD | 7.33e-03 | 2.20e-01 | 0.0338 |
123591 | TMEM266 | HTA11_6818_2000001011 | Human | Colorectum | AD | 5.06e-03 | 2.63e-01 | 0.0112 |
123591 | TMEM266 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 7.65e-20 | 5.44e-01 | 0.3005 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM266 | SNV | Missense_Mutation | rs756884747 | c.623N>A | p.Arg208Gln | p.R208Q | Q2M3C6 | protein_coding | deleterious(0) | possibly_damaging(0.845) | TCGA-AP-A1E1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMEM266 | SNV | Missense_Mutation | c.436N>A | p.Leu146Met | p.L146M | Q2M3C6 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TMEM266 | SNV | Missense_Mutation | c.358N>A | p.Leu120Ile | p.L120I | Q2M3C6 | protein_coding | tolerated(0.07) | probably_damaging(0.996) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TMEM266 | SNV | Missense_Mutation | novel | c.765A>T | p.Gln255His | p.Q255H | Q2M3C6 | protein_coding | deleterious(0.02) | probably_damaging(0.998) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
TMEM266 | SNV | Missense_Mutation | novel | c.463N>A | p.Leu155Ile | p.L155I | Q2M3C6 | protein_coding | tolerated(0.06) | possibly_damaging(0.592) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMEM266 | SNV | Missense_Mutation | rs776711597 | c.94G>A | p.Glu32Lys | p.E32K | Q2M3C6 | protein_coding | deleterious_low_confidence(0) | benign(0.197) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
TMEM266 | SNV | Missense_Mutation | c.358C>A | p.Leu120Ile | p.L120I | Q2M3C6 | protein_coding | tolerated(0.07) | probably_damaging(0.996) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
TMEM266 | SNV | Missense_Mutation | novel | c.542C>A | p.Ser181Tyr | p.S181Y | Q2M3C6 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-EY-A1GI-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMEM266 | SNV | Missense_Mutation | c.80C>A | p.Ser27Tyr | p.S27Y | Q2M3C6 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.862) | TCGA-05-4396-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
TMEM266 | SNV | Missense_Mutation | c.1517N>A | p.Pro506His | p.P506H | Q2M3C6 | protein_coding | deleterious_low_confidence(0.01) | possibly_damaging(0.639) | TCGA-38-4632-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | gemcitabine | PD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |